Enovix Corp Cash and Equivalents

Quick Answer

Enovix Corp reported Cash and Equivalents of $106.01 million for fiscal year 2025.

Enovix Corp Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $106.01M -61.1%
2024 $272.87M +17.1%
2023 $233.12M -27.8%
2022 $322.85M -16.2%
2021 $385.29M +1222.1%
2020 $29.14M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $335.50M +67.0% +146.7%
June 30, 2025 $135.98M -42.2% -28.4%
March 31, 2025 $189.87M -14.5% -30.4%
December 31, 2024 $272.87M +17.1% +35.8%
September 30, 2024 $200.91M -25.8% -14.5%
June 30, 2024 $235.10M -31.5% +5.8%
March 31, 2024 $222.15M -24.4% -4.7%
December 31, 2023 $233.12M -27.8% -13.9%
  • Enovix Corp showed a decrease of -61.1% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2020–2025 period, Enovix Corp’s cash and equivalents has grown by 263.8% (from $29.14 million to $106.01 million).
  • The most recent figure is from Enovix Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment